Stock Rich List
#14022 on the rich list of 14,644 insiders

Markus Warmuth

President & CEO at Monte Rosa Therapeutics. Based in Boston, Massachusetts.

$5.2M
in disclosed stock, −$70K (−1.32%) today
Live prices, last trade 3:55 PM ET
Rank
14022nd of 14,644
Companies held
1
Largest holding
GLUE, 100.0% of total
Latest SEC filing
Jul 16, 2026

What the $5.2M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Monte Rosa Therapeutics GLUE
Common Stock
Directly585,038$8.95$5.2M100.0%Form 4, Jul 16, 2026

Share counts are the amounts Markus Warmuth reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jul 16, 2026SoldGLUE9,500$23.18$220KView
Jun 1, 2026SoldGLUE4,998$19.41$97KView
Jun 1, 2026SoldGLUE468$19.73$9KView
May 1, 2026SoldGLUE5,467$18.92$103KView
Apr 14, 2026SoldGLUE8,000$17.64$141KView
Mar 2, 2026SoldGLUE5,466$17.92$98KView
Jan 7, 2026SoldGLUE309$24.57$8KView
Jan 7, 2026SoldGLUE1,450$23.88$35KView
Jan 7, 2026SoldGLUE3,707$23.24$86KView
Jan 5, 2026SoldGLUE10,135$15.17$154KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
14019Jason A. Kary
SVP, Keysight Technologies. Santa Rosa, CA
$5.2M−$64K (−1.21%)
14020James Lance Carter
President and CEO, HBT Financial. Bloomington, IL
$5.2M−$49K (−0.92%)
14021Paul C. Woelkers
Director, Fidelity D & D Bancorp. Moscow, PA
$5.2M−$78K (−1.46%)
14022Markus Warmuth
President & CEO, Monte Rosa Therapeutics. Boston, MA
$5.2M−$70K (−1.32%)
14023Soon Huat Lim
Chief Executive Officer, Trident Digital Tech Holdings
$5.2M−$3.6M (−40.96%)
14024Peter Leddy
See Remarks, Maravai LifeSciences Holdings. San Diego, CA
$5.2M−$131K (−2.44%)
14025Matthew McGrew
Executive Vice President, Danaher. Washington, DC
$5.2M−$15K (−0.28%)

Questions

How much stock does Markus Warmuth own?

Markus Warmuth holds $5,236,090 in listed stock based on SEC filings and current prices, mostly Monte Rosa Therapeutics (GLUE). That ranks 14022nd on the Stock Rich List.

Is this Markus Warmuth's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Markus Warmuth last buy or sell stock?

The most recent open-market trade on file is a sale of 9,500 GLUE shares on Jul 16, 2026 at $23.18.